FLS
67
2
V
60
2
GOOGL
74
2
T
44
2
JCI
35
4
ADSK
52
4
DD
67
11
MSFT
60
5
NTRS
35
5
SLB
41
2
HPE
17
5
FIS
48
5
OXY
46
-2
AVGO
42
2
ZTS
47
-16
NAVI
41
12
FRT
58
-5
EIX
58
2
UNH
46
-10
MKC
44
2
FLS
67
2
V
60
2
GOOGL
74
2
T
44
2
JCI
35
4
ADSK
52
4
DD
67
11
MSFT
60
5
NTRS
35
5
SLB
41
2
HPE
17
5
FIS
48
5
OXY
46
-2
AVGO
42
2
ZTS
47
-16
NAVI
41
12
FRT
58
-5
EIX
58
2
UNH
46
-10
MKC
44
2
Financhill
Back

AirNet Technology 10K Form

Sell
24

ANTE
AirNet Technology

Last Price:
1.06
Seasonality Move:
-16.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ANTE News And Ratings

See the #1 stock for the next 7 days that we like better than ANTE

ANTE Financial Statistics

Sales & Book Value

Annual Sales: $845K
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $2.65
Price / Book: 1.28

Profitability

EPS (TTM): -0.35110
Net Income (TTM): $-574K
Gross Margin: $-531K
Return on Equity: 0%
Return on Assets: -0.67%

AirNet Technology Earnings Forecast

Key AirNet Technology Financial Ratios

  • The Gross Profit Margin over the past 19 years for ANTE is -62.84%.
  • The Selling, General & Administrative Expenses for ANTE have been equal to 389.35% of Gross Profit Margin.
  • The Research & Development expenses have been 4.14% of Revenue.
  • The Interest Expense is -55.75% of Operating Income.
  • The Net Earning history of ANTE is -67.93% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 10 years.

AirNet Technology Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Media
Sector: Communication Services
Current Symbol: ANTE
CUSIP: 00941Q
Website: ir.airnetgroup.cn

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0.35
Quick Ratio: 0.27

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ANTE Technical Analysis vs Fundamental Analysis

Sell
24
AirNet Technology (ANTE) is a Sell

Is AirNet Technology a Buy or a Sell?

  • AirNet Technology stock is rated a Sell
    The current AirNet Technology [ANTE] share price is $1.16. The Score for ANTE is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.